Operating Expenses (Details) - USD ($)			3 Months Ended		9 Months Ended
Operating Expenses (Details) - USD ($)	Jun. 11, 2026	May 12, 2026	Sep. 30, 2026	Sep. 30, 2025	Sep. 30, 2026	Sep. 30, 2025	Jul. 15, 2026	Dec. 31, 2025
Operating Expenses [Line Items]
Cash paid	$ 1,000,000		$ 4,860,697		$ 4,860,697		$ 2,300,000	$ 701,602
Restricted shares	2,121,386	20,000,000
In-process research and development					$ 4,258,449
Grant-date price per share					$ 1.536
In Process Research and Development [Member]
Operating Expenses [Line Items]
In-process research and development					$ 3,258,449
Ordinary shares issued for in-process research and development (in Shares)					2,121,386
Intellectual Property [Member]
Operating Expenses [Line Items]
Intellectual property acquisition liability			1,000,000		$ 1,000,000
Outstanding intellectual property acquisition liability			750,000		750,000
Payment amount			$ 250,000		$ 250,000